gliclazide and Intestinal Diseases

gliclazide has been researched along with Intestinal Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Afzal, SM; Ali, N; Barnwal, P; Hasan, SK; Nafees, S; Parveen, R; Rashid, S; Shahid, A; Siddiqi, A; Sultana, S; Vafa, A	1

Other Studies

1 other study(ies) available for gliclazide and Intestinal Diseases

Article	Year
Partial protection by 18β Glycrrhetinic acid against Cisplatin induced oxidative intestinal damage in wistar rats: Possible role of NFkB and caspases. Pharmacological reports : PR, 2017, Volume: 69, Issue:5 Topics: Animals; Biomarkers; Caspases; Cisplatin; Gene Expression Regulation; Glutathione; Glycyrrhetinic Acid; Intestinal Diseases; Male; NF-kappa B; Oxidative Stress; Random Allocation; Rats; Rats, Wistar	2017

Article

Year

Partial protection by 18β Glycrrhetinic acid against Cisplatin induced oxidative intestinal damage in wistar rats: Possible role of NFkB and caspases.

Pharmacological reports : PR, 2017, Volume: 69, Issue:5

Topics: Animals; Biomarkers; Caspases; Cisplatin; Gene Expression Regulation; Glutathione; Glycyrrhetinic Acid; Intestinal Diseases; Male; NF-kappa B; Oxidative Stress; Random Allocation; Rats; Rats, Wistar

2017